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1058Objective: There is increasing awareness that erythrocyte transfusions after pediatric cardiac surgery have del-
eterious effects. Despite reports of decreased transfusion requirements associated with smaller cardiopulmonary
bypass circuits, the relationship between circuit prime volume and need for transfusion has not been systemat-
ically examined.
Methods: Pediatric patients at our institution who underwent cardiopulmonary bypass between January 2005
and December 2010 were reviewed. Demographics, intraoperative data, and transfusion of packed red blood
cells were retrospectively recorded. Cardiopulmonary bypass prime volumewas indexed by patient body surface
area. Logistic regression analysis was used to correlate these variables with need for transfusion.
Results: In the perioperative period, 1912 patients received transfusions and 266 did not. In univariate analysis,
indexed prime volume was a significant predictor of transfusion (odds ratio, 1.007; P<.001). Other significant
variables in univariate analysis included age, surgeon, Risk Adjustment for Congenital Heart Surgery 1
(RACHS-1) category, preoperative hemoglobin, total bypass time, aortic crossclamp time, use and duration
of deep hypothermic circulatory arrest, lowest body core temperature, and cardiopulmonary bypass flow rate.
Previous cardiac surgery was not a significant predictor. In multivariable analysis controlling for RACHS-1 cat-
egory, surgeon, minimal core body temperature, and preoperative hemoglobin, indexed prime volume remained
an independent predictor of transfusion (odds ratio, 1.006; 95% confidence interval, 1.005-1.007, P<.001).
Conclusions: Perioperative need for transfusion in pediatric cardiac surgical patients is independently related to
the prime volume of the cardiopulmonary bypass circuit. It therefore seems prudent to minimize circuit prime
volumes to avoid unnecessary use of blood products. (J Thorac Cardiovasc Surg 2013;145:1058-64)Recent publications have shown that the need for a blood
transfusion in the postoperative period may increase the du-
ration of mechanical ventilation and hospitalization in chil-
dren undergoing surgical repair of congenital heart
disease.1,2 Furthermore, even if donor blood is safe from
infections, there still remain significant morbidities
related to the use of donor packed red blood cells
(pRBCs), including anaphylactoid transfusion reactions.
Despite the almost universal agreement that avoidance of
blood products is desirable, there has not been a recent
evaluation of factors contributing to the use of blood
transfusions in this population. In the past decade,
advances in cardiopulmonary bypass (CPB) circuits have
resulted in the ability to have smaller prime volumes,
decreasing the patient’s initial intraoperative exposure toe Division of Pediatric Cardiology,a Department of Pediatrics, and the
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contribute to improved outcomes, especially in smaller
infants and children.
This study was designed to examine the factors that lead
to the need for transfusions of pRBCs in the perioperative
period and to examine whether CPB prime volume affects
the risk of receiving a pRBC transfusion in the perioperative
period in children undergoing surgery with CPB for
congenital heart disease.
MATERIALS AND METHODS
Study Population
This study was approved by the institutional review board of Columbia
University. All patients younger than 18 years who underwent cardiac sur-
gery with CPB at the Morgan Stanley Children’s Hospital of New York be-
tween January 1, 2005, and December 31, 2010, were considered for
inclusion. Patients undergoing ventricular assist device implantation, repair
of cardiac trauma, or reoperation for hemorrhage were excluded, because
these patients differ dramatically from other cardiac surgical patients in
transfusion strategy. Furthermore, patients undergoing heart transplant
were excluded because immunologic factors may play a role in whether
they receive a transfusion.
Study Design
Demographic, surgical, and perfusion related data were collected from
a prospectively collected institutional database. These data included sex,
age at surgery, surgeon, body surface area (BSA) in square meters (as cal-
culated according to the Haycock formula), surgical procedure, anatomicgery c April 2013
Abbreviations and Acronyms
BSA ¼ body surface area
CPB ¼ cardiopulmonary bypass
DHCA ¼ deep hypothermic circulatory arrest
MUF ¼ modified ultrafiltration
pRBCs ¼ packed red blood cells
RACHS-1 ¼ Risk Adjustment for Congenital
Heart Surgery 1
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Ddiagnosis, number of previous cardiac surgical procedures, number of pre-
vious cardiac surgical procedures with CPB, preoperative hemoglobin in
grams per deciliter, CPB circuit prime volume in milliliters, total CPB
time in minutes, aortic crossclamp time in minutes, deep hypothermic cir-
culatory arrest (DHCA) time in minutes, minimal core body temperature in
C, maximum CPB circuit flow rate in liters per minute, hospital stay in
days, and mortality. A separate clinical database was reviewed to assess
whether each patient had received any transfusions with pRBCs in the peri-
operative period, defined as the time from when the patient arrived in the
operating room (postoperative day 0) through postoperative day 6 (or hos-
pital discharge if sooner). Surgical procedures were risk categorized
according to the Risk Adjustment for Congenital Heart Surgery 1
(RACHS-1) method.3 The RACHS-1 method uses 6 categories of surgical
risk, with category 1 having the lowest risk and 6 the highest. Specific sur-
gical procedures are assigned to each category, so those surgical procedures
that did not fit into one of the RACHS-1 categories were labeled as ‘‘none.’’
Both CPB circuit prime volume and maximum CPB circuit flow rate were
indexed for BSA, resulting in the variables of indexed prime volume in mil-
liliters per square meter and indexed flow rate in liters per minute per
square meter. For analysis purposes, patients were divided into 2 groups,
those who received any volume of pRBC transfusion in the perioperative
period and those who did not.
Statistical Analysis
All continuous variables were examined for normality. Normal vari-
ables are expressed as mean  SD; nonnormal variables are expressed as
median with either range or interquartile range. Factors were compared be-
tween the transfusion groups with the Student t test, Mann-Whitney U test,
or c2 analysis as appropriate. Univariate logistic regression was used to
evaluate the association between each variable and the outcome of pRBC
transfusion. A multivariable model was then created to evaluate the associ-
ation of indexed prime volume to the outcome of pRBC transfusion after
controlling for other factors. All variables with a P value less than 0.1 in
the univariate analysis were considered for inclusion in the multivariable
model, and surgeon was chosen a priori to be in the model regardless of
statistical considerations. Other candidate variables were not included in
the final model if (1) they were not significant predictors of outcome
and (2) there was no appreciable effect on the remaining variables whether
or not they were included in the model (ie, a <10% change in the
b coefficient). All statistical tests were 2-sided. Statistical analyses were
performed with SPSS Statistics 18 for Windows software (IBM Corpora-
tion, Armonk, NY).
RESULTS
Population Demographics
The total number of patients meeting inclusion and
exclusion criteria for the study was 2268. Of these, 90
(4%) were further excluded for missing data required for
the calculation of the primary predictor variable of indexedThe Journal of Thoracic and Carprime volume (height, weight, BSA, or prime volume). This
left 2178 patients for inclusion and analysis. The median
age at surgery was 6 months (range, 1 day-17.9 years; inter-
quartile range, 25 days-2.8 years), and 58.3% of the pa-
tients were male. Weight at surgery ranged from 1.1 kg to
151 kg (median, 6.2 kg; interquartile range, 3.6-13 kg).
Simple structural heart disease was the indication for sur-
gery in 44.1% of cases, whereas 22.8% had cyanotic heart
disease, 5.1% had complex acyanotic heart disease, and
26.4% had single-ventricle physiology. In total, 652 pa-
tients(30%) had previously undergone cardiac surgery,
with 266 having more than 1 previous operation. Of these,
only 83 patients had previously undergone surgery that
did not involve CPB.
Operative Characteristics
Themost common surgical procedure performedwas ven-
tricular septal defect closure (9.6%), with total cavopulmo-
nary connection (8.8%), tetralogy of Fallot repair (8.3%),
and superior cavopulmonary anastomosis (8%) the second,
third, and fourth most frequent procedures, respectively.
The vast majority of procedures were classified as RACHS-
1 category 2 (37.5%) or category 3 (36.4%). RACHS-1 cat-
egory 1 procedures only accounted for 7% of all procedures,
and category 4 accounted for 11.1%. Only 1 procedure was
classified as RACHS-1 category 5, and 6% (131) were clas-
sified as category 6. There were 42 procedures (2.2%) that
were not classifiable under the RACHS-1 method, most of
which were repairs of pulmonary vein stenosis. Only 16 pa-
tients did not have a measured hemoglobin value within the
2-week period before surgery. The mean preoperative hemo-
globin value in the remaining 2162 patients (99%) was
13.6 2.3 g/dL. Absolute CPB circuit prime volume ranged
from 27 to 1400 mL. When indexed for patient BSA, the
mean prime volume was 780  300 mL/m2. The mean
CPB time was 104  49 minutes, with a mean indexed
flow rate of 2.3  0.7 L/(min/m2). Aortic crossclamp with
cardioplegia was used in 86.8% of procedures, with
a mean crossclamp time of 50.6  30.2 minutes. DHCA
was used in 32.6% of cases, with a mean arrest time of
31.4  17.8 minutes. The mean minimal core body temper-
ature was 31.3C  3.8C for patients in whom DHCAwas
not used and 18.8C  2.4C in those in whom it was.
Group Comparisons
When the total study population was divided into those
who required pRBC transfusion (n ¼ 1912) and those
who did not (n ¼ 266), differences in demographic and in-
traoperative factors became apparent (Table 1). Specifi-
cally, patients who did not require pRBC transfusions
were significantly older (5.7 vs 0.4 years; P<.001), heavier
(21.2 vs 5.5 kg; P < .001), and larger in BSA (0.8 vs
0.31 m2; P < .001). Patients who did not require
pRBC transfusion also tended to have a lower RACHS-1diovascular Surgery c Volume 145, Number 4 1059
TABLE 1. Demographic characteristics and clinical outcomes of patients, as divided between those who received at least 1 packed red blood cell
transfusion and those who did not
No transfusion (n ¼ 266) Transfusion (n ¼ 1912) P value
Age in (y, median and range) 5.7 (1 d-17.7 y) 0.4 (1 d-17.9 y) <.001
Weight (kg, median and range) 21.2 (1.8-150) 5.5 (1.1-151) <.001
BSA (m2, median and range) 0.8 (0.15-2.32) 0.31 (0.11-2.52) <.001
Diagnosis (no.) <.001
Simple structural heart disease 193 (72.6%) 767 (40.1%)
Complex acyanotic disease 1 (0.4%) 109 (5.7%)
Cyanotic heart disease 21 (7.9%) 476 (24.9%)
Single ventricle 49 (18.4%) 525 (27.4%)
Other 2 (0.8%) 35 (1.8%)
RACHS-1 category (no.) <.001
1 77 (28.9%) 75 (3.9%)
2 73 (27.4%) 744 (38.9%)
3 112 (42.1%) 681 (35.6%)
4 3 (1.1%) 239 (12.5%)
5 0 (0%) 1 (0.1%)
6 1 (0.4%) 130 (6.8%)
None 0 (0%) 42 (2.2%)
Previous cardiac surgery (no.) 80 (30.1%) 572 (29.9%) .96
Preoperative hemoglobin (g/dL, mean  SD) 14.3  2.2 (n ¼ 261) 13.5  2.3 (n ¼ 1901) <.001
Previous surgery with CPB (no.) 72 (27.1%) 497 (26%) .71
Prime volume (indexed to BSA as mL/m2, mean  SD) 444  207 826  279 <.001
CPB time (min, mean  SD) 80  45 107  48 <.001
Flow rate (indexed BSA as L/[min/m2], mean  SD) 2.25  0.35 2.35  0.77 .03
Crossclamp use (no.) 230 (86.5%) 1660 (86.8%) .87
Crossclamp time (min, mean  SD) 40  31 52  30 <.001
DHCA use (no.) 14 (5.3%) 696 (36.4%) <.001
DHCA time (min, median and range) 21 (12-45) 33 (2-144) .005
Hospital stay (d, median with interquartile range) 4.8 (3.6-7.0) 7.5 (5-13) <.001
Mortality (no.) 1 (0.4%) 86 (4.5%) .001
BSA, Body surface area; CPB, cardiopulmonary bypass; DHCA, deep hypothermic circulatory arrest; RACHS-1, Risk Adjustment for Congenital Heart Surgery 1.
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Dclassification, with a larger percentage being in RACHS-1
category 1 and fewer being in RACHS-1 categories 4, 5,
or 6. All patients who were not classifiable by the
RACHS-1 system required pRBC transfusions. Surpris-
ingly, there were no differences in the proportions of pa-
tients who had previous cardiac procedures or previous
procedures requiring CPB. The mean preoperative hemo-
globin value was significantly higher in the group who did
not require transfusion (14.3  2.2 vs 13.5  2.3 g/dL;
P<.001). The mean indexed CPB prime volume was also
lower in the group that did not receive pRBC transfusions
(444  207 vs 826  279 mL/m2; P< .001), as was the
mean total CPB time (80  45 vs 107  48 minutes;
P<.001). There was also a statistically significant but small
difference in the mean indexed flow rates, with patients who
required blood transfusion having a slightly higher flow
rate (2.35  0.77 L/[min/m2]) than those who did not
(2.25 0.35 L/[min/m2]; P¼ .03). There was no difference
between the groups in the use of aortic crossclamp with car-
dioplegia; however, the duration of aortic crossclamping
was significantly higher in patients who required pRBC
transfusion (52 30 vs 40 31 minutes; P<.001). Patients1060 The Journal of Thoracic and Cardiovascular Surwho did not require a pRBC transfusion were significantly
less likely to have had DHCA (5.3% vs 36.4%; P<.001),
and if DHCA was used, it was used for a shorter median
duration (21 vs 33 minutes; P ¼ .005).
Association With Other Outcomes
We also examined the relationship between requiring
pRBC transfusion and total hospital length of stay and mor-
tality (Table 1). Patients who did not receive pRBC transfu-
sion had a significantly shorter total hospital length of stay
with a median hospital stay of 4.8 days versus 7.5 days
(P<.001). Similarly, fewer patients who had not received
pRBC transfusion died during the postoperative hospitali-
zation (0.4% vs 4.5%; P ¼ .001).
Univariate Regression Analysis
To examine which factors were potentially associated
with the need for pRBC transfusion, a univariate logistic re-
gression was performed on all candidate factors, as shown
in Table 2. Because so few patients were classified in
RACHS-1 categories 4, 5, an 6, and their overall risk
appeared similar, these 3 categories were collapsed intogery c April 2013
TABLE 2. Univariate analysis of risk factors for requirement of
packed red blood cell transfusion
Variable
Unadjusted
odds ratio
95% Confidence
interval
P
value
Prime volume (as indexed
to BSA, mL/m2)
1.007 1.006-1.008 <.001
Age at surgery (y) 0.765 0.744-0.788 <.001
Surgeon <.001
RACHS-1 category
1 1 Reference —
2 10.464 7.024-15.588 <.001
3 6.243 4.288-9.088 <.001
4, 5, or 6 94.967 33.724-267.423 <.001
Preoperative hemoglobin
(g/dL)
0.869 0.823-0.918 <.001
Previous cardiac surgery 0.992 0.75-1.313 .958
Prior cardiac surgery with
CPB
0.946 0.709-1.264 .709
CPB time (min) 1.015 1.012-1.019 <.001
Aortic crossclamp use 1.031 0.708-1.501 .873
Aortic crossclamp time (min) 1.018 1.012-1.025 <.001
DHCA use 10.303 5.967-17.789 <.001
DHCA time (min) 1.045 1.008-1.083 .017
Minimal core body
temperature (C)
0.832 0.804-0.86 <.001
Maximum flow (as indexed
to BSA, L/[min/m2])
2.029 1.397-2.947 <.001
BSA, Body surface area; CPB, cardiopulmonary bypass; DHCA, deep hypothermic
circulatory arrest; RACHS-1, Risk Adjustment for Congenital Heart Surgery 1.
TABLE 3. Final multivariable model of risk factors for requiring
packed red blood cell transfusion after adjustment for operating
surgeon
Variable
Adjusted
odds ratio
95% Confidence
interval
P
value
Prime volume (as indexed
to BSA, mL/m2)
1.006 1.005-1.007 <.001
RACHS-1 category
1 1 Reference —
2 5.195 3.109-8.680 <.001
3 3.927 2.315-6.662 <.001
4, 5, or 6 6.995 2.075-23.577 .002
Minimal core body
temperature (C)
0.87 0.833-0.908 <.001
Preoperative hemoglobin
(g/dL)
0.811 0.749-0.877 <.001
BSA, Body surface area; RACHS-1, Risk Adjustment for Congenital Heart Surgery 1.
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unclassifiable under the RACHS-1 method were not in-
cluded in that analysis or in any subsequent analyses with
the RACHS-1 variable, decreasing the total population
to 2136.
Multivariable Regression Analysis
A multivariable model (n ¼ 2087) was constructed, ex-
amining all candidate variables identified from the univari-
ate model. Indexed prime volume (as the primary variable
of interest) and the categoric variable of surgeon were
placed in the model a priori. Variables were removed
from the model if after addition they were nonsignificant
(P>.05) and if their addition had no effect on the estimates
for the other variables in the model. This resulted in the
final multivariate model shown in Table 3. In the final
model, RACHS-1 category was an independent predictor
of pRBC transfusion, with higher odds of requiring
pRBC transfusion in the higher RACHS-1 risk categories
(Table 3). Both core body temperature and preoperative he-
moglobin remained as independent risk factors, and their
presence significantly affected the coefficient values for
the RACHS-1 and surgeon variables; as such, both are in-
cluded in the final model.
After controlling for surgeon, minimal core body temper-
ature, preoperative hemoglobin, and RACHS-1 category,The Journal of Thoracic and Carindexed CPB prime volume remained a significant
independent predictor of the need for pRBC transfusion,
with an odds ratio of 1.006 (95% confidence interval,
1.005-1.007), or a 0.6% increased odds of requiring
pRBC transfusion for every increase of 1 mL/m2 in CPB
prime volume. To place this risk estimate in clinically rele-
vant terms, the model was rerun to examine a 10-mL change
in absolute prime volume for patients at the 10th, 50th, and
90th percentiles of BSA in our study population (0.2, 0.34,
and 0.9 m2). For patients at these sizes, a 10-mL change in
absolute CPB prime volume resulted in indexed prime vol-
ume changes of 50, 29, and 11 mL/m2, respectively. The
odds ratios for these changes were 1.35, 1.19, and 1.07;
that is, a 10-mL change in absolute prime volume increased
the odds of requiring pRBC transfusion by 35% in a patient
with a BSA of 0.2 m2, by 19% in a patient with a BSA of
0.34 m2, and by 7% in a patient with a BSA of 0.9 m2.
Figure 1 illustrates the relationship between the odds of re-
quiring pRBC transfusion and absolute CPB circuit prime
volume for different patient sizes. As shown, the odds of re-
quiring pRBC transfusion increase 2-fold at increases of 25
mL for a BSA of 0.2 m2, 60mL for a BSA of 0.5m2, 120mL
for a BSA of 1 m2, and 175 mL for a BSA of 1.5 m2.DISCUSSION
In this study of more than 2000 consecutive pediatric pa-
tients undergoing cardiac surgery with CPB, we found that
CPB prime volume (as indexed to BSA) was a significant
independent predictor of requirement of pRBC transfusion
in the perioperative period, even after controlling for sur-
geon, operative risk, preoperative hemoglobin value, and
minimal core temperature during CPB, which also serve
as independent risk factors themselves. Certainly the mor-
bidities associated with blood transfusions in this popula-
tion have been well established; however, this is the first
study to identify the potentially modifiable variable ofdiovascular Surgery c Volume 145, Number 4 1061
FIGURE 1. Curves representing the change in odds of receiving a blood transfusion in relation to an absolute change in cardiopulmonary bypass circuit
prime volume for patients with body surface areas (BSA) of 0.2, 0.5, 1, and 1.5 m2. Note that a doublings of the odds ratio occur at 20, 60, 120, and 175 mL,
respectively, for these different sizes of patients.
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for blood transfusion after pediatric cardiac surgery.
Although the effect of indexed prime volume at first appears
modest, we have demonstrated that even a decrease of 10 or
20 mL in circuit prime volume can have a profound effect
on small children. Despite this robust finding, however,
there are limitations to the current study that should be
explored.
The sample population of this study was taken from con-
secutive pediatric cardiac surgical patients at a single large-
volume institution. One of the strengths of this study is the
uniformity of treatment, because there were no significant
institutional changes to perioperative management during
the study period with regard to blood transfusion. During
the 5-year study period, however, there were a total of 4 sur-
geons who operated at our institution, and certainly it could
be argued that surgical operative technique influences the
need for transfusion. Furthermore, the surgical experience
was widely varied among the 4 surgeons, from less than 5
years to more than 20 years. Even after controlling for
this variation, however, the odds of requiring transfusion
as related to CPB prime volume remained remarkably
steady and significant. In addition to surgeon variability,
our population may not be representative of all surgical pro-
grams. Because of the high proportion of high-risk surgical
procedures (45% RACHS-1 category 3 or greater, and only
7% RACHS-1 category 1), it is unclear that similar findings
would be found in a surgical population consisting of
mostly low-risk procedures, probably because the overall
risk of transfusion would be much lower to begin with.
Perhaps the most important limitation of this study is the
fact that it arises from observational data. Although1062 The Journal of Thoracic and Cardiovascular Sura prospective study with defined criteria for transfusion
would be ideal, we have minimized any biases by using pro-
spectively collected surgical data, which significantly lim-
ited the amount of missing data and the potential for
recall or information biases. In fact, only 4% of patients
identified as meeting inclusion criteria had missing data, re-
sulting in exclusion from the analysis.
Our institution does not have a single standard target he-
moglobin concentration during (or after) CPB. Typically, an
estimated postdilutional hematocrit less than 25%will trig-
ger the addition of pRBCs to the prime. In some younger or
cyanotic patients, however, pRBCs are added to maintain
a postdilutional hematocrit of at least 30%, or even 35%.
As such, subjects within the study may have had different
target hemoglobin concentrations, as determined by the
clinical team. Because of the observational nature of this
study, it is impossible to determine what threshold was
used for transfusion in each case because there are many
factors that may have caused a patient to receive blood
products in the operating room, including, but not limited
to the clinical judgment of the surgeon, anesthesiologist,
and any other provider involved in the care of the patient.
It is impossible to control for all of these factors, but it is un-
likely that the combination of these factors would correlate
directly with the indexed CPB circuit prime volume. Other
factors, such as patient age, preoperative hemoglobin value,
or length of CPB support may also influence the clinical de-
cision to transfuse; however, these factors were examined
and controlled for in the analysis and did not have any effect
on the risk of transfusion as it related to indexed CPB prime
volume. Furthermore, the interaction between age and in-
dexed prime volume was examined and determined to begery c April 2013
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sionist who constructs the CPB circuit may influence the
transfusion practice in the operating room. There were nu-
merous perfusionists involved in these cases, however,
and the incremental nature of the relationship between in-
dexed prime volume and the need for transfusion makes
this a less likely confounding factor. Furthermore, bypass
circuit volumes and prime composition were standard
among perfusionists. Our center has 8 standard circuits,
ranging in prime volume from 180 to 1100 mL. The choice
of circuit is typically made on the basis of the required cir-
cuit flow rate, as illustrated in Table 4.
It is important to note that our standard of care for pedi-
atric patients on CPB does not include the routine use of
modified ultrafiltration (MUF), which has been proposed
as a mechanism for decreasing the need for transfusion, es-
pecially in smaller patients and those with long CPB times.4
How indexed CPB prime volume affects the need for trans-
fusion in centers that routinely use MUF is unclear; how-
ever, we believe that minimizing prime volume and
avoiding the need for MUF is a superior approach to the
high-risk and infant patient. It is the unique techniques of
CPB circuit minimization that have allowed for successful
surgical approaches in the smaller infants without the use
of pRBC transfusions or MUF. Throughout the years, we
have used a multitude of circuit modifications, including
many that have been previously reported in the literature
by other groups, such as remote pump heads, minimizing
extraneous tubing, removing redundant circuits, and newer
and smaller volume oxygenators.5,6
Despite the limitations, this study adds important new
knowledge to the reasons that children undergoing cardiac
surgery require blood transfusions. As the negative conse-
quences of blood transfusions in this population become
clearer, interventions aimed at decreasing the likelihood
of requiring a blood transfusion will become more com-
monplace. Williams and colleagues7 evaluated factors that
lead to transfusion requirements in 1999 and found that
age at surgery was the most predictive of bleeding and the
need for pRBC transfusion. This group also identified other
risk factors, such as surgical complexity, length of DHCA,
and minimal core temperature, similar to our results.TABLE 4. Pump flow rates and prime volumes for the 8 standard
circuits used during the study time frame
Circuit Desired flow (L/min) Prime volume (mL)
1 0.650 180
2 0.650 220
3 >0.650-1.2 270
4 >1.2-1.5 375
5 >1.5-1.9 610
6 >1.9-3.2 640
7 >3.2-5 950
8 >5 1100
The Journal of Thoracic and CarAlthough our study did not identify age at surgery as an in-
dependent risk factor, it is likely that the indexed prime vol-
ume was higher in the younger patients; thus the effect of
age seen in their study may actually have been mediated
through prime volume. More recently Szekely and associ-
ates8 looked at factors that influenced the need for transfu-
sions of all blood products in an effort to adjust for these
factors in associating transfusions with outcomes. Although
not the primary aim of their study, they found weight at the
time of surgery was the most predictive of the need for
pRBC transfusion, even after adjustment for the need for
preoperative mechanical ventilation, creatinine clearance,
aortic crossclamp time, and intraoperative fluid balance.
Similar to age, we hypothesize that the effect of weight at
the time of surgery could also be mediated through indexed
prime volume, making these results consistent with our
study as well. Further supporting our findings is the inclu-
sion of weight at the time of surgery as a risk factor for re-
quiring transfusion in even some adult reports.9 Because
most adult bypass circuits are of a standard volume, smaller
patient weight results in higher indexed prime volumes, and
these results could show the same mechanism as our pedi-
atric study.
The effects of bypass prime volume on the risk of trans-
fusion are magnified in smaller patients as exhibited in
Figure 1. Thus even modest changes in the circuit composi-
tion can create real changes in transfusion risk. For example
the use of a pediatric arterial filter (eg, Affinity Pediatric Ar-
terial Filter; Medtronic Perfusion Systems, Brooklyn Park,
Minn), instead of the adult version from the same manufac-
turer (eg, Affinity Arterial Filter; Medtronic Perfusion Sys-
tems) can decrease circuit prime volume by 30mL.We have
used both filters successfully in circuits to support patients
with a BSA range of 0.5 to 1.5 m2. During the 5-year study
period, 580 patients with a BSA between 0.5 and 1.5 m2 un-
derwent surgery at our institution. If all these patients had
had the circuit prime volume decreased by the previously
mentioned technique, after controlling for RACHS-1 cate-
gory, preoperative hemoglobin, and minimal core body
temperature, the average decrease in the odds of receiving
a transfusion would be 22%. This would have resulted in
approximately 90 additional patients avoiding transfusion
(15% of the total surgical population).
In summary, it appears that CPB circuit prime volume is
a potentially modifiable risk factor for the need for blood
transfusion in pediatric patients undergoing cardiac surgery
with CPB. Dramatic changes in the risk of transfusion can
occur with even modest changes to the absolute circuit
prime volume, because the relationship is based on the pa-
tient’s BSA as well. As little as a 20-mL change in prime
volume can effect a 2-fold increase or decrease in the risk
of requiring a blood transfusion in an infant, and even
a modest 150-mL change in an adult-sized circuit can mod-
ify the patient’s risk substantially. Although further studydiovascular Surgery c Volume 145, Number 4 1063
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ranted, these results would seem to promote the concept
of circuit miniaturization as an immediate way to decrease
this risk.
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